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Purpose: While many studies investigate the cytoskeletal properties of the lens with respect to cataract development,
examinations of how these molecular structures interact are few. Myosin light chain kinase (MLCK),  actin,  and myosin
are present on the crystalline lenses of chickens. The purpose of this experiment was to determine whether contractile
proteins found on the lens play a role in the optical functions of the lens at rest, and during accommodation.
Methods: Eyes of 6-day old white Leghorn chicks (Gallus gallus domesticus) were enucleated, with the ciliary nerve
intact. One eye was treated with the MLCK inhibitor 1-(5-iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine
hydrochloride (ML-7) and the other eye with vehicle only. Three concentrations of ML-7 were used: 1 µM, 10 µM, and
100 µM. The back vertex focal lengths (BVFLs) were measured before, during, and after accommodation using an optical
laser scanning monitor (Scantox™). To further confirm ML-7 activity, western blotting was performed to detect whether
MLCK was inhibited.
Results: Western blots confirmed that MLCK was inhibited at all three ML-7 concentrations. Ten µM ML-7 treatments     
led to longer BVFLs at rest (p=0.0338), while 100 µM treatments led to opposite changes, resulting in shorter BVFLs
(p=0.0220). While 1 µM treatments did not lead to significant optical changes (p=0.4416), BVFLs were similar in pattern
to those of the 10 µM group. ML-7 had no effects on accommodative amplitudes (p=0.7848).
Conclusions: Inhibition of MLCK by ML-7 led to differential changes in BVFLs that presumably affected lenticular
integrity. No apparent effect on accommodative amplitudes was observed.
Accommodation in humans was first described by von
Helmholtz as a cascade of events involving ciliary muscle
contraction, reduction in the tension of the zonules connecting
the ciliary muscle and the lens, and finally, a change of the
lens shape so that its surfaces are more curved, resulting in a
higher refractive power [1]. The crux of this model is that the
lens is pliable, and as such, undergoes mechanical stress
during accommodation.
Motility and stress of a cell involve cytoskeletal
components such as intermediate filaments, actin, myosin,
and adhesion proteins such as the cadherins. While many
studies investigate the cytoskeletal properties of the lens with
respect to cataract development, very little information
pertaining to how these molecular structures interact, or are
altered during accommodation, exists. Previous studies
revealed a network of filamentous f-actin polygonal arrays
that are colocalized with myosin in the anterior epithelium of
the lens [2,3]. A similar arrangement of actin and myosin was
observed at the posterior surface on the capsule in chicken
lenses, along with other proteins, such as N-cadherin, myosin
light chain kinase (MLCK), and additional proteins that are
involved in contraction [4]. These findings may suggest that
lenticular forces could contribute to accommodation. Cellular
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movements are known to occur when there is a presence of
both actin and myosin; their interactions form the basis of a
molecular motor, and this motor is found in muscle tissue as
well as in non-muscle tissue.
The purpose of this study was to determine whether the
contractile proteins found on the lens play a role in the optical
functions of the lens at rest, and during accommodation. Since
MLCK is found in lenticular cells, an MLCK inhibitor, such
as 1-(5-iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-
diazepine hydrochloride (ML-7), would be expected to disrupt
the cytoskeletal proteins on the lens, such as actin and myosin.
It is known that phosphorylation of MLCK leads to various
physiological processes, including contraction of smooth
muscle, fibroblast contraction as well as cytoskeletal
modeling by (actin) stress fibers in nonmuscle cells [5,6].
Therefore, inhibiting MLCK on the lens would interfere with
the possible contraction that is taking place, resulting in a
change in accommodative amplitude.
METHODS
Eye dissections and lens treatments: White leghorn hatchling
chicks (Gallus gallus domesticus) were obtained from Maple
Leaf Poultry,  New  Hamburg,  Ontario, Canada  and  were  fed
ad  libitum  with  lights  on  a  14:10  light:dark  cycle.  Chicks
were   cared   for   in  accordance  with  the  guidelines  of  the
Canadian Council  on Animal Care;  their management  is  in
accordance  with  guidelines  established by  the Institute  for
Laboratory Animal Research.
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Chicks were sacrificed by decapitation when they were 6
days old. Heads were bisected along the sagittal plane. Eyes
were enucleated and the posterior globe was removed except
for a wedge containing the intact ciliary nerve and ganglion.
For optical function assessments, the sclera was removed as
close to the lens as possible without damaging the ciliary
muscle so that the lens could be viewed by the cameras located
in the Scantox™ In Vitro Lens Assay System (XTOX
Scientific, Napean, ON). For the western blot procedure, the
vitreous was also removed before removal of the posterior
portion of the lens capsule. All dissections were performed in
oxygenated (95% oxygen, 5% carbon dioxide) Tyrode’s
saline (TS: 134 mM NaCl, 3 mM KCl, 20.5 mM NaHCO3,
1 mM MgCl2, 3 mM CaCl2, in deionized water).
For all experiments, either the left or the right eye of each
pair was treated for 15 min with 1 µM ML-7 in 0.001% (v/v)
ethanol (EtOH) in TS, 10 µM ML-7 in 0.01% (v/v) EtOH in
TS or 100 µM ML-7 in 0.1% (v/v) EtOH in TS while the
fellow eyes of each pair was treated with the appropriate
concentration of vehicle (0.001% (v/v) EtOH in TS, 0.01%
(v/v) EtOH in TS or 0.1% (v/v) EtOH TS, respectively).
Measurements of lenticular optical function: Following either
ML-7 or vehicle treatment, each eye was pinned to a
Sylgard® (Dow Corning, Midland, MI) washer, with the
cornea facing down. The eye was then placed into a glass
chamber with an access tube. A custom-made suction
electrode, connected to a Grass S43 stimulator (Astro-Med,
Inc., Brossard, QC), was passed through the access tube before
plugging the rest of the small tube with petroleum jelly. The
chamber was filled with 20% (v/v) fetal bovine serum (PAA
Laboratories, Etobicoke, ON) in TS to visualize the refracted
beams. The ciliary nerve was suctioned into the electrode tip.
Lenses were scanned using the Scantox™ In Vitro Lens
Assay System (XTOX Scientific) as previously described
[7,8]. In brief, a low-powered helium laser passed through the
lenses at 0.131 mm intervals away from the optical axis and
the back vertex focal lengths (BVFLs), the distances from the
back vertex of the lens to where refracted beams cross the
optical axis, were measured using the Scantox™ system.
Scans were obtained before, during and after accommodation.
Accommodation of the intact eye was induced by electrical
stimulation of the ciliary nerve (30 Hz, 1–1.5 mA).
Statistical analysis of measurements of optical function: For
each scan, the three central BVFLs were removed because of
the presence of sutures, regions of optical disorder that can
over- or under-estimate back vertex focal lengths. For each
pair of eyes, the scan with the smallest number of beams was
the standard for all other scans for that chick. BVFLs were
converted from millimeters into dioptric values using the
refractive index of water, n=1.33. Accommodative amplitude
was calculated as the difference between the mean pre-
stimulation and stimulation vergence values for each eye.
Optical quality of the lens was assessed using two parameters,
focal length variability, which increases the amount of scatter
due to optical degradation, and spherical aberration (SA),
which is a measure of the deviation of marginal rays from
those at the optical axis.
Mixed model repeated measures analysis of variance
(ANOVA) tests were used to determine changes in back
vertex focal lengths (BVFLs), focal length variability and
spherical aberration (SA) as a function of inhibition
treatments (ML-7 versus vehicle), dosage groups (1 µM,
10 µM, and 100 µM) and accommodative state (pre-
stimulation, stimulation and post-stimulation). Changes
associated with accommodative amplitude were also assessed
using a mixed model repeated measures ANOVA as a function
of inhibition treatments and dosage group. One-way repeated
measures ANOVAs with Bonferroni-corrected multiple
comparison tests were used as post-hoc tests for further
analysis of interactions between dependent or repeated data.
Greenhouse-Geisser correction factors were used for epsilon
<0.75. Results were significant at p≤0.05.
Western blot analysis: Western blots of the relative amounts
of phosphorylated myosin in the presence of ML-7 and its
vehicle (ethanol; EtOH) were used to confirm that ML-7 had
an inhibitory effect on myosin light chain kinase activity. The
posterior capsule of the lenses was removed then placed in
cold 20 µl of Phosphate-Buffered Saline (PBS: 137 mM,
NaCl, 3 mM  KCl, 101 mM  Na2HPO4, 2 mM KH2PO4, in
deionized water). Capsule samples were then centrifuged
(3,786× g for 10 min at 4 °C) and the supernatant collected.
The total protein concentration of each sample was quantified
using the BioRad DC protein assay™ (500–0111; BioRad
Laboratories, Mississauga, ON). Capsule samples were mixed
with Biostab (62513; Biomol, Hamburg, Germany), a
biomolecular storage solution (5:1 ratio, respectively) before
storing at –80 °C.
Capsule samples were diluted with gel loading buffer
(GLB: 100 mM Tris base [pH 7.4], 5% [v/v] glycerol, 2.5%
[v/v] SDS, 0.03% [w/v] bromophenol blue, in water) then
heated (3 min at 95 °C). For each western blot, samples (1 µl)
were run at the same concentrations to ensure equal loading
of protein. Concentrations below 1 µg/µl were not used.
Samples were loaded on a polyacrylamide gel (PhastGel™,
gradient 10–15, 57–6781–00; GE Healthcare Bio-Sciences,
Mississauga, ON) and run on a GE Phastsytem™ Separation
& Control Unit (GE Healthcare, Uppsala, Sweden, at 250 V,
15 °C, 30 min) with SDS Buffer strips (17–0515–01; GE
Healthcare Bio-Sciences). Proteins were electro-transferred
onto wet immuno-blot polyvinylidene-difluoride (PVDF)
membranes (162–0176; BioRad Laboratories) and
membranes were dried (RT, 15 min followed by 50 °C at 45
min).
Membranes were blocked (blocking buffer [BB]: 8% [w/
v] skim milk powder in 0.5% [v/v] Tween-20 in PBS [PBS-
T], 45 min) then washed in PBS-T (5 min) before submerging
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in anti-phospho-myosin (M6068; Sigma, St. Louis, MO;
1:1000 in 90% PBS-T: 10% BB, 4 °C overnight). Membranes
were then washed (4×5 min, PBS-T) and anti-phospho-
myosin was labeled with horseradish peroxidase-conjugated
goat anti-rabbit IgG solution (H & L, ab6721; Abcam,
Cambridge, MA; 1:1000 in 90% PBS-T: 10% BB; 1 h, RT).
Membranes were washed (3×5 min, PBS-T) followed by a
final wash (PBS, 1 min). Proteins were visualized with
chemiluminescent ECL™ detection (RPN2132, RPN2133;
Amersham Biosciences, Mississauga, ON) and imaged using
the Storm 840™ imaging system (Molecular Dynamics,
Sunnyvale, CA). Protein expression was measured by
quantifying the amount of fluorescence using the
ImageQuant™ software.
RESULTS
Measurements of optical functions of the lens: As expected,
differences in the mean back vertex focal lengths (BVFLs)
were detected as a function of accommodative state, with
BVFLs during accommodation shorter than those at rest for
all three dosage groups (p<0.0001; Figure 1). ML-7 at all
doses inhibited MLCK activity, as shown by the relatively
lower amounts of phosphorylated myosin in western blots of
the lenticular posterior capsules treated (intensity relative to
respective vehicle: 1 µM 50.7%; 10 µM 47.2%; 100 µM:
16.7%; Figure 1: insets), but did not have an overall (main)
effect on BVFLs (Figure 1). However, interaction between
dosage group and inhibition treatments was detected
(p=0.0138), indicating that ML-7 had differential effects on
BVFLs. Post-hoc tests indicated that both the 10 µM and
100 µM ML-7 treatments had effects on BVFLs (p=0.0338
and p=0.0220, respectively) that were opposite. For the 10 µM
group, BVFLs of ML-7-treated eyes were significantly longer
than those for vehicle-treated eyes during the two resting
states (Figure 1B; pre-accommodation mean±s.d.:
20.10±1.65 mm versus 19.28±1.48 mm, respectively,
p=0.0027; post-accommodation: 20.02±1.57 mm versus
19.10±1.29 mm, p=0.0015), but not during accommodation
(15.61±1.18 mm versus 15.23±1.02 mm, p=0.6477; Figure
1B). While differences in mean BVFLs for the 1 µM group
were not significant (Figure 1A; p=0.4416), BVFLs were
similar in pattern to those of the 10 µM group, with ML-7-
treated eyes showing slightly, although not significantly
longer BVFLs than their fellow vehicle-treated eyes (pre-
accommodation: 20.22±1.44 mm versus 19.94±0.85 mm,
respectively, p=1.000; accommodation: 15.98±1.00 mm
versus 15.19±1.35 mm, p=0.4623; post-accommodation:
20.11±1.35 mm versus 19.54±1.11 mm, p=1.000,
respectively; Bonferroni; Figure 1A). ML-7 treatment
(100 µM) resulted in the opposite trend to the two lower doses,
with ML-7-treated eyes showing shorter BVFLs compared to
their fellow control eyes (Figure 1C; pre-accommodation:
19.22±1.64 mm versus 19.85±1.90 mm, p=0.0132;
accommodation: 14.83±1.34 mm versus 15.54±1.65 mm,
p=0.0082; post-accommodation: 19.02±1.66 mm versus
19.54±1.66 mm, p=0.0615).
Figure 1. Effects of ML-7 on mean back vertex focal lengths
(±s.e.m). Line graphs show the effects of lenses treated with ML-7
(filled symbols) and vehicle (empty symbols) pre-, during, and post-
accommodation. A: 1 µM (n=4), B; 10 µM (n=12), C: 100 µM (n=9).
For all three dosage groups, focal lengths for the accommodation
state were significantly shorter than those at rest (p<0.0001; denoted
by asterisks). Daggers denote significant differences in BVFLs
between ML-7- and vehicle-treated eyes at the same functional state.
Insets: western blots showing relative amounts of phosphorylated
myosin for all dosage groups. Please refer to the text for relative
intensity values.
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Measurements of accommodation of the lens: Although
ML-7-induced differences in BVFLs were detected for pre-
stimulation states for the 10 µM and 100 µM ML-7 treatment
groups, accommodative amplitudes were not different across
dosage groups (p=0.7848), inhibition treatments (p=0.6112),
nor was any interaction detected between these two factors
(p=0.0646; Figure 2).
DISCUSSION
Effects of ML-7 on lenticular optics: This study was
performed to determine whether contractile microfilaments
could affect the optics or accommodative amplitudes of the
lens. The data indicated that ML-7 has effects on the optics of
the lens, resulting in longer mean BVFLs for lower doses of
ML-7 in eyes at rest. The lower BVFLs indicate a change in
the shape of the lens, presumably a flattening, which could
arise as a result of a loss of tone or stiffness of the lens or of
the ciliary muscles that surround and directly articulate the
lens. Ciliary muscle in chicks is skeletal in nature and is
therefore likely unaffected by ML-7; since ML-7
preferentially inhibits smooth muscle MLCK (smMLCK)
[9-11], and given that smMLCK expression is lower than that
of skeletal MLCK in skeletal muscles [12], we speculate that
ML-7 effects on ciliary muscle, if any, would be negligible.
Moreover, unpublished data from our laboratory indicate that
isolated chicken lenses exposed to low concentrations of
ML-7 become softer (as assessed by lower amounts of force
exerted by the lens upon being compressed between two metal
plates in solution; data not shown), which, together with the
observations that ML-7 had no effect on accommodative
amplitudes from contraction of the ciliary muscles (Figure 2),
suggest that ML-7 acted directly via changes to lenticular
integrity and consequently, lenticular shape, rather than via
Figure 2. Effects of ML-7 on accommodative amplitudes (±s.e.m).
Bar graphs show the accommodative amplitudes of 1 µM (n=4),
10 µM (n=12), and 100 µM (n=9) ML-7-treated (filled bars) and
vehicle-treated (empty bars) eyes, respectively.
the ciliary muscle. Our western blots of the posterior lens
capsule confirming that ML-7 treatments were effective in
reducing the phosphorylation of myosin (Figure 1, insets)
would seem to further support a role for the lens, and
moreover, that loss of stiffnes was a result of ML-7-induced
inhibition of MLCK and its subsequent effects on myosin and
actin at the lens capsule. Although we did not carry out
experiments to confirm whether myosin and actin
distributions in the lenses were altered with ML-7, other
investigators have shown that ML-7 reduces the stiffness of
nonmuscle cells such as fibroblasts [13], and induces loss of,
or prevents formation of actin stress fiber bundles in human
carcinoma [14], fibroblast [14-16] and endothelial cells [17,
18]. A study by Collin and colleagues [19] showing that
relaxation of baby hamster kidney cell podosomes is
associated with the disappearance of actin stress fibers adds
support to our findings that ML-7-induced loss of stiffness is
almost certainly related to loss of actin stress fiber formation.
The possibility that changes in BVFLs were a result of
changes to the refractive index of the lens must also be
acknowledged. Presumably, for such a decrease in refractive
index to occur, and within the time span observed, ML-7
would have to directly affect the crystallin proteins. However,
we do not believe that this could occur without causing
changes to the optical quality of the lenses and both the focal
length variability and the negative spherical aberrations that
are typical of avian lenses were observed in our experiments
to be unaffected by ML-7 (data not shown). We know of no
mechanism for ML-7 to affect the down-regulation of the
crystallin proteins.
That treatment of 100 µM ML-7 results in the opposite
response, i.e., shorter, rather than longer BVFLs, would
suggest that the cytoskeletal integrity and stiffness of the
lenses were also opposite to lenses treated with lower doses
of ML-7. Cytoskeletal distributions were not examined in this
study but preliminary results of a parallel study by our group
indicate that a 100 µM dose of ML-7 leads to stiffer (isolated)
chick lenses [20]. A dual or biphasic response for ML-7 in
other nonmuscle cells was reported by Takizawa and
colleagues [14], who showed that cell-spreading behaviors
were opposite depending on the the dose of ML-7. That
BVFLs of lenses were diametrical in our study might be
related to the specificity of ML-7 and its mode of inhibition.
At higher doses, ML-7 inhibits kinases other than MLCK,
such as protein kinase A (PKA) and protein kinase C (PKC;
Ki values of 21 µM and 42 µM, respectively; [21]). Of the two
kinases, PKA is the likelier candidate as an enzyme whose
inhibition could lead to opposite effects on cytoskeletal
integrity and therefore by inference, on the stiffness of the lens
and BVFLs. Microinjection of PKA into living fibroblast cells
leads to PKA-induced dephosphorylation of MLCK and actin
filament disassembly [22], while inhibition of PKA activity
in endothelial cells results in the opposite, i.e., actin stress
fiber formation [23]. However, a role for PKA remains
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uncertain as it assumes that the effects of PKA inhibition are
stronger than those of MLCK inhibition, which is not known.
It should also be noted that opposing behaviors may not be
related to secondary inhibition effects of ML-7, but rather to
other regulatory proteins that differentially mediate the
sensitivities of the cytoskeletal components to ML-7 [14].
As observed in previous experiments [7,8], optical scans
for all lenses showed negative spherical aberrations (SAs),
which increased with accommodation (p=0.0194; data not
shown), although no changes in SA were detected as a
function of ML-7 treatment (p=0.1933; data not shown).
These results suggest ML-7 effects were similar across the
entire anterior and posterior surfaces of the lens; observations
that BVFLs were longer with ML-7 are also consistent with
the idea of a global effect of ML-7 on the lens.
Effect of ML-7 on accommodation: Unlike a previous study,
which showed that different resting state BVFLs could have
effects on accommodative amplitudes [7], no changes in
accommodative amplitudes were observed with ML-7
treatment (Figure 2), despite ML-7-dependent differences in
resting state BVFLs (Figure 1). Differences in the
accommodative amplitudes arising from changes in lenticular
integrity may have been too subtle to detect. Alternatively,
contributions by the lens may have been masked by the
contractile forces applied by the ciliary muscle; ciliary muscle
had about a 10-fold larger contractile force across all groups
(~20 D, Figure 2) compared to the equivalent change in power
between ML-7-treated and vehicle-treated eyes at rest (~2 D,
calculated from BVFL vergences, calculation not shown).
In summary, inhibition of MLCK led to changes in the
optics of the lens, resulting in a change in BVFL, and therefore
presumably, to lenticular shape and integrity. However,
putative integrity changes were not reflected in the
accommodative amplitudes observed, which may have been
a consequence of masking effects by larger ciliary muscle
contractions. Thus, we could not unequivocally rule out a role
for contractile proteins in accommodation. A preliminary
study is planned to determine whether lenticular integrity
changes arising from alterations to cytoskeletal proteins can
affect accommodation.
ACKNOWLEDGMENTS
The authors would like to thank Dr. Jake Sivak, Dr. Matt
Vijayan, Angela Backman, Liem Ho, Elizabeth Joyce, and
Miriam Heynen for their helpful guidance and assistance. A
segment of this work was previously presented at an
Association for Research in Vision and Ophthalmology
meeting. This work was funded by the Natural Sciences and
Engineering Research Council of Canada (V.C.) and the
Canadian Optometric Education Trust Fund (S.L.).
REFERENCES
1. Helmholtz Hv. Southall JPC. Helmholtz's treatise on
physiological optics. Translated from the 3d German ed. New
York: Dover Publications; 1962.
2. Rafferty NS, Scholz DL, Goldberg M, Lewyckyj M.
Immunocytochemical evidence for an actin-myosin system in
lens epithelial cells. Exp Eye Res 1990; 51:591-600. [PMID:
2249732]
3. Rafferty NS, Rafferty KA, Ito E. Agonist-induced rise in
intracellular calcium of lens epithelial cells: effects on the
actin cytoskeleton. Exp Eye Res 1994; 59:191-201. [PMID:
7835408]
4. Bassnett S, Missey H, Vucemilo I. Molecular architecture of the
lens fiber cell basal membrane complex. J Cell Sci 1999;
112:2155-65. [PMID: 10362545]
5. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle
and nonmuscle myosin II: modulated by G proteins, kinases,
and myosin phosphatase. Physiol Rev 2003; 83:1325-58.
[PMID: 14506307]
6. Kamm KE, Stull JT. Dedicated myosin light chain kinases with
diverse cellular functions. J Biol Chem 2001; 276:4527-30.
[PMID: 11096123]
7. Choh V, Sivak JG. Lenticular accommodation in relation to
ametropia: the chick model. J Vis 2005; 5:165-76. [PMID:
15929643]
8. Choh V, Sivak JG, Meriney SD. A physiological model to
measure effects of age on lenticular accommodation and
spherical aberration in chickens. Invest Ophthalmol Vis Sci
2002; 43:92-8. [PMID: 11773018]
9. Saitoh M, Ishikawa T, Matsushima S, Naka M, Hidaka H.
Selective inhibition of catalytic activity of smooth muscle
myosin light chain kinase. J Biol Chem 1987;
262:7796-801. [PMID: 3108259]
10. Kelley SJ, Thomas R, Dunham PB. Candidate inhibitor of the
volume-sensitive kinase regulating K-Cl cotransport: the
myosin light chain kinase inhibitor ML-7. J Membr Biol
2000; 178:31-41. [PMID: 11058685]
11. Bain J, McLauchlan H, Elliott M, Cohen P. The specificities of
protein kinase inhibitors: an update. Biochem J 2003;
371:199-204. [PMID: 12534346]
12. Herring BP, Dixon S, Gallagher PJ. Smooth muscle myosin
light chain kinase expression in cardiac and skeletal muscle.
Am J Physiol Cell Physiol 2000; 279:C1656-64. [PMID:
11029314]
13. Schäfer A, Radmacher M. Influence of myosin II activity on
stiffness of fibroblast cells. Acta Biomater 2005; 1:273-80.
[PMID: 16701806]
14. Takizawa N, Ikebe R, Ikebe M, Luna EJ. Supervillin slows cell
spreading by facilitating myosin II activation at the cell
periphery. J Cell Sci 2007; 120:3792-803. [PMID: 17925381]
15. Katoh K, Kano Y, Amano M, Kaibuchi K, Fujiwara K. Stress
fiber organization regulated by MLCK and Rho-kinase in
cultured human fibroblasts. Am J Physiol Cell Physiol 2001;
280:C1669-79. [PMID: 11350763]
16. Mizutani T, Haga H, Koyama Y, Takahashi M, Kawabata K.
Diphosphorylation of the myosin regulatory light chain
enhances the tension acting on stress fibers in fibroblasts. J
Cell Physiol 2006; 209:726-31. [PMID: 16924661]
17. Chen B, Guo XH, Wang SY, Huang XL, Huang QB. Myosin
light-chain kinase contributes to short-term endothelial cell
cytoskeletal alteration induced by serum from burned rats. Di
Yi Jun Yi Da Xue Xue Bao 2004; 24:481-4. [PMID:
15151812]
Molecular Vision 2011; 17:2759-2764 <http://www.molvis.org/molvis/v17/a298> © 2011 Molecular Vision
2763
18. Lee CF, Haase C, Deguchi S, Kaunas R. Cyclic stretch-induced
stress fiber dynamics - dependence on strain rate, Rho-kinase
and MLCK. Biochem Biophys Res Commun 2010;
401:344-9. [PMID: 20849825]
19. Collin O, Na S, Chowdhury F, Hong M, Shin ME, Wang F,
Wang N. Self-organized podosomes are dynamic
mechanosensors. Curr Biol 2008; 18:1288-94. [PMID:
18760605]
20. Choh V, Won G-J, Fudge DS. The Effects of a Myosin Light
Chain Kinase Inhibitor on the Stiffness of Avian Crystalline
Lenses. ARVO Annual Meeting; 2011 May 1-5; Fort
Lauderdale (FL).
21. Krarup T, Jakobsen LD, Jensen BS, Hoffmann EK. Na+-K
+-2Cl- cotransport in Ehrlich cells: regulation by protein
phosphatases and kinases. Am J Physiol 1998;
275:C239-50. [PMID: 9688855]
22. Lamb NJ, Fernandez A, Conti MA, Adelstein R, Glass DB,
Welch WJ, Feramisco JR. Regulation of actin microfilament
integrity in living nonmuscle cells by the cAMP-dependent
protein kinase and the myosin light chain kinase. J Cell Biol
1988; 106:1955-71. [PMID: 3290222]
23. Liu F, Verin AD, Borbiev T, Garcia JG. Role of cAMP-
dependent protein kinase A activity in endothelial cell
cytoskeleton rearrangement. Am J Physiol Lung Cell Mol
Physiol 2001; 280:L1309-17. [PMID: 11350812]
Molecular Vision 2011; 17:2759-2764 <http://www.molvis.org/molvis/v17/a298> © 2011 Molecular Vision
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China.
The print version of this article was created on 19 October 2011. This reflects all typographical corrections and errata to the
article through that date. Details of any changes may be found in the online version of the article.
2764
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed. Originally published: 
Luck, S., & Choh, V. (2011, October 22). Effects of a myosin light chain kinase inhibitor on the optics and accommodation of the avian crystalline lens. Molecular Vision, 17, 2759-2764. 
from http://www.molvis.org/molvis/v17/a298/
